(NASDAQ: SOPH) Sophia Genetics Sa's forecast annual revenue growth rate of 31.02% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 13.37%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.6%.
Sophia Genetics Sa's revenue in 2024 is $62,371,000.On average, 2 Wall Street analysts forecast SOPH's revenue for 2024 to be $5,200,441,086, with the lowest SOPH revenue forecast at $5,195,483,563, and the highest SOPH revenue forecast at $5,205,398,608. On average, 2 Wall Street analysts forecast SOPH's revenue for 2025 to be $6,719,660,805, with the lowest SOPH revenue forecast at $6,568,717,291, and the highest SOPH revenue forecast at $6,870,604,318.
In 2026, SOPH is forecast to generate $9,165,350,153 in revenue, with the lowest revenue forecast at $9,165,350,153 and the highest revenue forecast at $9,165,350,153.